Alerts will be sent to your verified email
Verify Email
ABATEAS
|
Abate AS Industries
|
Balaxi Pharma.
|
Khemani Distributors
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-969.59 % | 27.3 % | 12.08 % |
|
5yr Avg Net Profit Margin
|
1.26 % | 11.03 % | 8.87 % |
|
Price to Book
|
1.64 | 1.09 | 0.0 |
|
P/E
|
378.08 | 13.39 | 19.13 |
|
5yr Avg Cash Conversion Cycle
|
543.66 Days | 154.28 Days | 62.78 Days |
|
5yr Average Interest Coverage Ratio
|
-1300.88 | 57.05 | 51.65 |
|
5yr Avg ROCE
|
86.26 % | 36.52 % | 13.64 % |
|
5yr Avg Operating Profit Margin
|
1.33 % | 16.64 % | 5.49 % |
|
5 yr average Debt to Equity
|
16.73 | 0.09 | 0.11 |
|
5yr CAGR Net Profit
|
n/a | -5.76 % | n/a |
|
5yr Average Return on Assets
|
-129.78 % | 18.47 % | 10.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.56 % | 65.99 % | 75.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 30.19 % |
|
Change in Promoter Holding (3 Yrs)
|
-4.31 % | -6.87 % | 47.36 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Abate AS Industries
|
Balaxi Pharma.
|
Khemani Distributors
|
|---|